Ha, H.I.; Yoon, H.J.; Song, C.; Kim, E.T.; Suh, D.-S.; Kim, K.H.; Na, Y.J.; Song, Y.J.
Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Curr. Oncol. 2024, 31, 6711-6722.
https://doi.org/10.3390/curroncol31110495
AMA Style
Ha HI, Yoon HJ, Song C, Kim ET, Suh D-S, Kim KH, Na YJ, Song YJ.
Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Current Oncology. 2024; 31(11):6711-6722.
https://doi.org/10.3390/curroncol31110495
Chicago/Turabian Style
Ha, Hyeong In, Hyung Joon Yoon, Changho Song, Eun Taeg Kim, Dong-Soo Suh, Ki Hyung Kim, Yong Jin Na, and Yong Jung Song.
2024. "Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea" Current Oncology 31, no. 11: 6711-6722.
https://doi.org/10.3390/curroncol31110495
APA Style
Ha, H. I., Yoon, H. J., Song, C., Kim, E. T., Suh, D.-S., Kim, K. H., Na, Y. J., & Song, Y. J.
(2024). Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Current Oncology, 31(11), 6711-6722.
https://doi.org/10.3390/curroncol31110495
